Target Name: MARK1
NCBI ID: G4139
Other Name(s): Microtubule affinity regulating kinase 1, transcript variant 2 | MARK1_HUMAN | Par-1c | Serine/threonine-protein kinase MARK1 (isoform 1) | MARK | MARK1 variant 2 | microtubule affinity regulating kinase 1 | Par1c | Serine/threonine-protein kinase MARK1 (isoform 2) | Microtubule affinity regulating kinase 1, transcript variant 1 | MARK1 variant 1 | MAP/microtubule affinity-regulating kinase 1 | KIAA1477 | Serine/threonine-protein kinase MARK1 | PAR1 homolog c

MARK1: A Protein Involved in Microtubule Dynamics and Signaling

MARK1, also known as Microtubule affinity regulating kinase 1 or Kinesin-6, is a protein that plays a critical role in the regulation of microtubules, which are dynamic cytoskeletal structures that are essential for cell division, transport, and intracellular signaling. MARK1 is a non-profit protein that was discovered through a combination of biochemical, cellular, and biophysical studies. Since its discovery, MARK1 has gained significant interest as a potential drug target or biomarker due to its unique mechanism of action and its involvement in various cellular processes.

The protein MARK1 was first identified as a component of the microtubule network in the early 1990s by researchers who used a technique called Biochemical assay for protein-protein interactions. They found that MARK1 interacted with the protein p21, which is a key regulator of the microtubule network. This interaction between MARK1 and p21 led to the conclusion that MARK1 might be involved in the regulation of microtubule dynamics.

To further validate this hypothesis, researchers used a variety of cellular and biophysical techniques to study the behavior of MARK1 in the context of microtubule dynamics. Specifically, they found that MARK1 was essential for the proper formation and stability of microtubules. required for the assembly and disassembly of microtubules, as well as for the regulation of microtubule dynamics. These findings provide strong evidence for the role of MARK1 in the regulation of microtubules.

In addition to its role in microtubule dynamics, MARK1 has also been shown to play a critical role in various signaling pathways. For example, MARK1 has been shown to be involved in the regulation of cell growth, as well as in the regulation of cell survival and differentiation. Specifically, MARK1 has been shown to interact with various signaling proteins, including TGF-β1, which is a well-known regulator of cell growth and differentiation.

Given its unique mechanism of action and its involvement in various cellular processes, MARK1 has gained significant interest as a potential drug target or biomarker. Researchers have been exploring the potential targets of MARK1 in order to develop new treatments for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the main challenges in studying MARK1 is its complex cellular and biophysical behavior. MARK1 is a protein that is expressed in a wide range of cell types, and its behavior can be affected by a variety of factors, including the concentration of its precursor protein , the presence of certain chemical groups on its amino acids, and the activity of various enzymes. These factors make it difficult to study MARK1 in a controlled and precise manner.

To overcome these challenges, researchers have used a variety of techniques to study the behavior of MARK1. One of the main approaches is to use biochemical assays, such as protein-protein interactions or protein kinase assays, to study the interactions between MARK1 and other proteins . These assays can provide valuable information about the specificity and mechanism of MARK1's interactions.

Another approach is to use live cell imaging techniques, such as time-lapse microscopy or super-resolution microscopy, to study the behavior of MARK1 in the context of microtubule dynamics. These techniques can provide high-resolution images of MARK1 in action, and can help to reveal the mechanisms of its behavior.

Finally, researchers have used computational tools, such as molecular docking, to study the potential targets of MARK1. These tools can predict the binding of MARK1 to specific protein targets, and can help to identify potential drug targets or biomarkers.

In conclusion, MARK1 is a protein that has

Protein Name: Microtubule Affinity Regulating Kinase 1

Functions: Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2 and MAP4. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3)

More Common Targets

MARK2 | MARK2P5 | MARK2P9 | MARK3 | MARK4 | MARS1 | MARS2 | MARVELD1 | MARVELD2 | MARVELD3 | MAS1 | MAS1L | MASP1 | MASP2 | MAST1 | MAST2 | MAST3 | MAST4 | MASTL | MAT1A | MAT2A | MAT2B | MATCAP1 | MATCAP2 | MATK | MATN1 | MATN1-AS1 | MATN2 | MATN3 | MATN4 | MATR3 | Matrix Metalloproteinase (MMP) | MAU2 | MAVS | MAX | MAZ | MB | MB21D2 | MBD1 | MBD2 | MBD2-MBD3 complex | MBD3 | MBD3L1 | MBD3L2 | MBD3L3 | MBD3L4 | MBD3L5 | MBD4 | MBD5 | MBD6 | MBIP | MBL1P | MBL2 | MBLAC1 | MBLAC2 | MBNL1 | MBNL1-AS1 | MBNL2 | MBNL3 | MBOAT1 | MBOAT2 | MBOAT4 | MBOAT7 | MBP | MBTD1 | MBTPS1 | MBTPS2 | MC1R | MC2R | MC3R | MC4R | MC5R | MCAM | MCAT | MCC | MCCC1 | MCCC2 | MCCD1 | MCCD1P1 | MCEE | MCEMP1 | MCF2 | MCF2L | MCF2L-AS1 | MCF2L2 | MCFD2 | MCFD2P1 | MCHR1 | MCHR2 | MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6